Red and blue light therapy for menopause oral symptoms is worth understanding if your mouth has changed with menopause. It can start during perimenopause: a burning tongue, a mouth that never feels wet, gums that bleed more easily, or food that suddenly tastes wrong. These problems are common. In a survey of 3,211 peri- and postmenopausal women, 71.2% reported dry mouth (García-Alfaro et al., 2025). A 2025 meta-analysis found gum disease (periodontitis) in 55% of postmenopausal women and dry mouth in 50%, with tooth loss in a quarter (Rajpal et al., 2025). Women also develop burning mouth syndrome at about five times the rate of men. Postmenopausal women aged 50 to 89 have the highest rates (Kohorst et al., 2014).
Research on red and blue light now reaches each of these symptoms, but at very different levels of evidence. Burning mouth syndrome has the most, from randomized trials and meta-analyses up to a 2026 clinical practice guideline. Bone and bacteria are still mostly studied in the lab.
Key Takeaways
- Burning mouth syndrome has the strongest evidence. In 2026, the World Association for Photobiomodulation Therapy issued clinical practice guidelines for burning mouth syndrome, rating the evidence Level I. The largest randomized trial, using 632.6 nm red light with oral cooling, reduced pain nearly five times more than drug therapy (a vitamin B12 tablet and a baking-soda rinse) at 12 weeks.
- In lab studies, red light raises cellular energy and calms inflammation, and blue light kills microbes. In clinical trials, light therapy increased saliva flow and eased dry-mouth symptoms. Blue light works by activating natural pigments inside certain bacteria and yeasts, with no added chemical.
- Important gaps remain in the light therapy research for menopause. None of the trials reviewed here made menopause an entry requirement.
What Happens to the Mouth During Menopause
Estrogen acts on the mouth as well as the reproductive system, because the mouth lining and the salivary glands carry estrogen receptors. A narrative review notes that falling estrogen affects the oral lining much as it affects vaginal tissue, which can lead to thinning and atrophy (Ciesielska et al., 2022). A 2026 review of 50 studies traced how falling estrogen reaches the gums and saliva. Estrogen receptors and bone metabolism are two of the shared pathways it describes; salivary gland function is another (Butera et al., 2026).
Dry mouth tends to build over time. In data summarized by a 2022 narrative review, 17.8% of women reported dryness before menopause. That rose to 23.3% during menopause and the five years after, then to 29.2% at five to nine years after. By ten or more years after menopause, it reached 34.5% (Ciesielska et al., 2022). A comparison of 200 women found dry mouth in 48% of women after menopause, compared with 18% of women before it. Burning was reported by 20% versus 2%, and altered taste by 45% versus 19% (Chorge et al., 2026). Medications add to the problem: taking more than three oral medications a day nearly triples the odds of dry mouth (Stoopler et al., 2024). Dry mouth has real consequences. People with dry mouth have about three times the odds of Candida overgrowth and oral thrush (Molek et al., 2022).
A 2026 systematic review of nine studies and 1,330 women looked at the gums after menopause. Several of those studies, though not all, found more gum attachment loss and deeper gum pockets (Civiletto-S. Martín et al., 2026).
Burning mouth syndrome causes chronic burning pain in a mouth that looks healthy. Across biopsy studies, people with burning mouth syndrome had 30% to 60% lower density of small nerve fibers in the mouth lining (Kouri et al., 2024). Loss of the protective effect of hormones after menopause is one hypothesis for why these nerves are affected (Jääskeläinen, 2018). A 2026 review found a consistent link between menopause and burning mouth syndrome, alongside thyroid problems and long-term medication use (Qaderi et al., 2026). The symptoms often travel together. Among 952 postmenopausal women seen at one oral medicine clinic, 26.5% had burning mouth syndrome. Of those women, 63.1% also had taste changes and 48.0% had oral dryness (S.R. et al., 2026).
Standard treatment often falls short. A Cochrane review covering research through 2015 found "insufficient evidence to support or refute the use of any interventions" for burning mouth syndrome (McMillan et al., 2016). Hormone therapy helps some women. But for women older than 60, or more than 10 years past menopause, The North American Menopause Society (now The Menopause Society) states that its benefit-risk balance "appears less favorable" (The North American Menopause Society, 2022). Burning mouth syndrome peaks in women aged 70 to 79, at 70.3 cases per 100,000 per year (Kohorst et al., 2014). The women burning mouth affects most are therefore the women for whom hormone therapy is less favored. For daily care alongside any treatment, see The Best Oral Care Routine for Adults in 2026.
Dr. Sutherland, DDS, who reviewed this article, explains where light therapy fits for women who have tried standard options and still struggle:
I always start with the basics. Before anything else, a dentist should check for an infection or a medication side effect, because those are treatable, and some women do best on hormone therapy or a prescription. The trouble is that burning mouth and long-term dry mouth often hang on after all of that. And the further a woman is past menopause, the less hormone therapy tends to suit her. That's where red light therapy gets interesting to me. It works on the tissue itself. In the lab it calms inflammation, and in clinical trials it has eased burning mouth pain, enough that the World Association for Photobiomodulation Therapy now has guidelines for it. If you've been told to just live with it, it's worth raising with your dentist.— Dr. Sutherland, DDS
How Red Light Therapy Works for Menopausal Oral Symptoms
Red light therapy, known clinically as photobiomodulation (PBM), uses red light (about 620 to 700 nm) and near-infrared light (above 700 nm). Inside cells, an energy-producing enzyme absorbs most of the light. That raises the cell's energy and sets off other effects, such as the release of a molecule that relaxes blood vessels (Hamblin, 2017). The same review notes that "one of the most reproducible effects of PBM is an overall reduction in inflammation." Many clinical trials in the mouth used near-infrared lasers. For a plain-language overview, see The Science of Red Light Therapy.
Red Light Therapy for Burning Mouth Syndrome
In 2026, the World Association for Photobiomodulation Therapy (WALT) issued clinical practice guidelines for primary burning mouth syndrome in a position paper. It rated the evidence Level I, with a strong recommendation (Hanna et al., 2026). Burning mouth syndrome was the only one of the six facial nerve-pain conditions reviewed to receive full clinical practice guidelines.
A 2025 umbrella review of 15 meta-analyses, covering 204 randomized trials and more than 9,000 people, rated 35 health outcomes. Pain relief in burning mouth syndrome was one of only five benefits to reach moderate certainty, the highest level any outcome in the review reached. Its effect was also large by the authors' own benchmark (Son et al., 2025). That result draws on a 2023 meta-analysis of randomized trials with 550 patients, in which light therapy reduced burning pain significantly more than sham treatment (Lu et al., 2023). An earlier meta-analysis of 12 trials and 574 patients also found significantly less pain with light than with placebo (Zhang et al., 2020).
Clonazepam is a prescription drug used for burning mouth syndrome. In a network meta-analysis of 24 trials, light therapy reduced pain by about as much as clonazepam (−1.90 versus −1.88 points against placebo). The evidence for light therapy was rated lower in certainty (Alvarenga-Brant et al., 2023). A 2025 meta-analysis of 13 studies found red laser reduced pain and improved quality of life compared with placebo. In the one head-to-head trial it included, laser therapy produced less pain than clonazepam (Okuhara et al., 2025).
A 2026 evidence map covered 130 studies and 6,879 people. It concluded that, against inactive treatment, light therapy shows the clearest short-term pain-relief signal for burning mouth syndrome. It described the drug and supplement evidence as limited and inconsistent (Calabrò et al., 2026).
Results From Burning Mouth Clinical Trials
The largest randomized trial, published in 2025, enrolled 128 patients at two hospitals in China. It tested 632.6 nm red light, alone or combined with oral cooling. The comparison groups received oral cooling alone or standard drug therapy (a vitamin B12 tablet plus a baking-soda rinse) (Lu et al., 2025). At 12 weeks, red light plus cooling produced a nearly fivefold greater reduction in pain than drug therapy. It also reduced anxiety nearly tenfold more than drug therapy at seven weeks, with no severe side effects. People in the trial averaged about 60 years old, and more than 85% were women. In a 12-month follow-up of 93 of the patients, 68 (73.1%) responded to treatment. The authors concluded that red light, alone or with cooling, gave lower pain recurrence and longer-lasting relief than cooling or drug therapy alone (Lu et al., 2026). Among responders treated with red light alone, 33.3% had pain return during follow-up.
In a 2024 randomized, single-blind trial, 89 patients were assigned to laser therapy, laser plus clonazepam, sham laser, or clonazepam alone. After four weeks, burning fell significantly in both laser groups and not with sham or clonazepam alone, although the four groups did not differ significantly from one another (Garcia Martinez et al., 2024). A 2023 randomized trial compared light therapy with electrical nerve stimulation, and light produced the better response during follow-up (Medeiros et al., 2023).
The authors of a randomized, double-blind pilot study chose 40 women of post-menopausal age (average age 62) with burning mouth syndrome, because postmenopausal women are the patients most often seen with the condition. They received 800 nm near-infrared laser or sham light twice weekly for four weeks (Scardina et al., 2020). Burning scores fell from 7 to 3 with real light and from 7 to 5 with sham. Two months after treatment ended, the light group stayed at 3 while the sham group returned to 7, and the authors describe "a lasting improvement in symptoms" in the light group.
A non-randomized feasibility trial compared light therapy with standard pain medication in 28 patients with nerve-related mouth pain, 19 of them with burning mouth syndrome. At one month, 810 nm laser therapy cut pain from 7.6 to 3.9, compared with 8.2 to 6.8 for medication (Hanna et al., 2022). Every patient in the medication group needed a higher dose by three months, while none of the 18 light therapy patients needed added pain medication through nine months of follow-up. Taste improved with light therapy but not with medication, and the improvement lasted through nine months. Eating and drinking improved mainly with light therapy.
Which wavelength works best is still open. A 2022 meta-analysis concluded that red laser protocols in particular improved pain and quality of life (Camolesi et al., 2022). In a 2025 trial, red light at 660 nm was tested against two near-infrared wavelengths, 810 and 975 nm, in 63 patients, 53 of whom completed treatment. All three significantly reduced pain, with no significant difference between them, and the two near-infrared wavelengths also eased numbness. The groups differed in power and dose as well, so the trial did not isolate wavelength alone (Ge et al., 2025).
Nerve and Blood Vessel Research in Burning Mouth Syndrome
Burning mouth syndrome is linked to damaged small nerve fibers in the mouth lining (Kouri et al., 2024), which makes research on light and nerve health relevant. In rodent studies summarized by a 2025 review, red and near-infrared light raised a protein that supports nerve health. The same review found that light reduced pain in animal models and in human nerve-pain conditions such as diabetic neuropathy (Martins et al., 2025). In a 2026 animal study, light restored normal levels of a nerve growth signal in rats with nerve injury and increased a key protein in the nerve's protective coating (Oliveira et al., 2026). A 2021 review found that red and near-infrared light supported recovery of jaw nerves injured during oral surgery (Ravera et al., 2021).
People with burning mouth syndrome show changes in the tiny blood vessels (capillaries) of the mouth lining. Researchers have proposed that this disturbed circulation helps explain the burning (Scardina et al., 2020). In the 2020 pilot trial of 40 women of post-menopausal age, near-infrared laser therapy narrowed and lengthened these capillary loops. Sham treatment produced no significant change (Scardina et al., 2020). The authors linked symptom relief to the narrowing of the capillaries. Placebo relief, by contrast, was temporary and unrelated to any change in circulation. In cell and animal studies, 632.8 nm red light promoted the growth of new blood vessels in human vascular cells and in healing rat skin wounds (Zhang et al., 2022). Light therapy research also covers other kinds of mouth pain; see Red and Blue Light Therapy for Dental Pain.
Red Light Therapy for Dry Mouth
The largest review of light therapy for dry mouth is a 2025 meta-analysis of 30 randomized trials and 1,250 patients. It found that light therapy increased resting saliva flow by 0.22 mL per minute and significantly reduced dry-mouth severity (Derikvand et al., 2025). Effects were stronger in dry mouth caused by cancer radiotherapy. An earlier meta-analysis of 14 trials also found that light therapy increased resting saliva flow compared with placebo (Golež et al., 2021).
One randomized trial looks a lot like the women most affected by menopausal dry mouth. Of its 60 patients, 47 had dry mouth caused by medicines, and the treated group was 93% women with an average age of 65. The trial compared 810 nm laser therapy with sham treatment for six weeks. Saliva flow and oral quality of life improved significantly, and the gains held at one year (Ferrández-Pujante et al., 2022). A blinded, placebo-controlled trial enrolled 41 patients whose blood-pressure medicines caused dry mouth. In that trial, 808 nm laser therapy significantly increased saliva flow, by 75% in the authors' description (Varellis et al., 2024). Dry mouth caused by medicines responded better than other causes to physical stimulation such as laser therapy, according to a scoping review, while Sjögren's disease responded least (Melo et al., 2023).
A review looked at cancer patients treated with radiotherapy. It concluded that LED light covering larger areas of the salivary glands "appears to be promising" compared with pinpoint laser (Oliveira et al., 2024). In the 12-month follow-up of the largest burning mouth trial, the authors identified dry mouth as a possible risk factor for burning mouth pain returning (Lu et al., 2026).
Red Light Therapy for Gum Inflammation and Bone
One lab study used inflamed stem cells from the ligament that holds teeth in place. In those cells, 650 nm red LED light raised cellular energy and lowered two key inflammation signals. When researchers blocked energy production, the anti-inflammatory effect disappeared (Yamauchi et al., 2022). Inflamed gum cells grown in the lab produced less of a molecule that drives inflammation when treated with 630 nm LED light (Chen et al., 2021). In another lab study, gum surface cells were exposed to live oral microbes. Cells first treated with red (615 nm) and near-infrared (880 nm) LED light made more of their own antimicrobial proteins and survived better. They also kept a stronger barrier and cleared more damaging reactive molecules (Tanum et al., 2024).
Clinical trials show benefits when light is added to professional deep cleaning (scaling and root planing). A meta-analysis of seven randomized trials found that adding laser therapy to deep cleaning improved gum pocket depth at one and two months. It also lowered an inflammation marker. Added benefits were not seen at three and six months (Ren et al., 2017). A randomized trial of 19 patients added 660 nm LED light to deep cleaning. At the most damaged sites, the light significantly reduced pocket depth and attachment loss (Chen et al., 2020). For the full evidence base, see Red Light Therapy for Gum Disease.
Estrogen deficiency is one recognized driver of bone loss, alongside aging itself, and the processes behind osteoporosis and gum disease overlap (Yu et al., 2022). The light therapy evidence for bone is preclinical. In rats with osteoporosis caused by removal of the ovaries, 808 nm light combined with a guided bone regeneration membrane improved new bone formation (Alves et al., 2020). In a similar rat model, 890 nm laser plus a bone graft left significantly smaller bone defects than the osteoporosis drug alendronate plus the same graft (Gazor et al., 2021).
Blue LED light drove bone-building activity in dental pulp stem cells grown in the lab, through a different cell pathway from the one red light uses (Chen et al., 2022). A follow-up study found that 405 nm blue light followed by 810 nm near-infrared light increased bone-building markers in these cells and in mice (Kim et al., 2023).
Red Light Therapy for Taste Changes
In one comparison study, 45% of postmenopausal women reported taste changes (Chorge et al., 2026). Most published light therapy research on taste studies other causes of taste loss. In a small, non-randomized 2022 trial of patients with nerve-related mouth pain, taste improved with light therapy but not with pain medication (Hanna et al., 2022). In cancer care, a triple-blind, placebo-controlled trial enrolled 112 women receiving chemotherapy for breast cancer. Red and near-infrared laser therapy to the tongue reduced both measured and self-reported taste loss and improved quality of life (Malta et al., 2022). Among 85 stem cell transplant patients in a randomized trial, 660 nm red laser significantly lowered rates of weakened, lost, and distorted taste compared with placebo (Ferreira et al., 2024). Outside cancer care, a randomized trial enrolled 70 people with taste changes after COVID-19. Red laser therapy improved taste more than sham treatment by weeks seven and eight, with both groups also receiving smell training (Parreira et al., 2024).
Evidence From Other Estrogen-Sensitive Tissue
The vaginal lining offers a useful parallel, because it shares estrogen receptors with the mouth and also thins after menopause (Ciesielska et al., 2022). A randomized, double-blind, placebo-controlled trial enrolled 65 postmenopausal women. In that trial, 808 nm laser therapy significantly reduced urinary leakage, and the women also reported less vaginal dryness and burning (Pereira et al., 2026). In a study with no comparison group, 27 postmenopausal women were treated with 660 nm red light. All of them had healthy vaginal tissue scores, with no thinning, three months after treatment (Wu et al., 2026). A 2019 review set out the scientific reasons for the therapy, concluding on preliminary evidence that it "is safe and appears to be efficacious." (Lanzafame et al., 2019).
How Blue Light Therapy Targets Oral Microbes
Blue light that kills microbes covers violet-blue to blue wavelengths, about 405 to 470 nm (Hiltch et al., 2026). It works differently from red light. Certain bacteria and yeasts contain natural light-sensitive pigments. Blue light activates these pigments, which then make a form of oxygen that damages the microbe from within (Wang et al., 2017). Because no chemical is added, blue light therapy differs from photodynamic therapy. Photodynamic therapy uses a light-activated dye or rinse.
Blue Light for Candida and Oral Thrush
Candida yeast causes oral thrush, and dry mouth makes thrush more likely. Saliva normally helps keep Candida in check, and after menopause women have lower levels of a salivary protein that fights fungi (Ciesielska et al., 2022). Thirty minutes of 405 nm blue LED light, with no added chemical, completely stopped colony formation in lab biofilms of C. albicans and C. glabrata (Tsutsumi-Arai et al., 2019). On denture material in the lab, the same wavelength stopped mixed Candida and bacterial biofilms from regrowing for 12 hours and reduced markers of sticking and biofilm building (Tsutsumi-Arai et al., 2022). When a 2021 lab study compared colors, 450 nm blue light on its own reduced C. albicans biofilm formation by about 65% and broke up mature biofilms by about 60%. Red and green light worked only with an added dye (Bapat et al., 2021).
Blue Light for Gum Disease Bacteria
Gum disease (periodontitis) was the most common oral condition in a 2025 meta-analysis of postmenopausal women, found in 55% of them (Rajpal et al., 2025). A major gum disease bacterium, Porphyromonas gingivalis, was killed by blue light in a lab study, apparently through DNA damage triggered by the bacterium's own pigment (Yoshida et al., 2017). Dark-pigmented gum bacteria were selectively killed in lab cultures and in human plaque samples, while at least one non-pigmented species was left unaffected (Soukos et al., 2005). In a lab biofilm containing four species, blue light cut P. gingivalis and Fusobacterium nucleatum by about half and halved the biofilm's thickness (Shany-Kdoshim et al., 2019).
Human studies of blue light for gum health are few and mixed. In a small study of 11 people, 455 nm blue light was applied to one side of the mouth twice daily for four days. The other side was left untreated for comparison. On the treated side, the proportions of P. gingivalis and Prevotella intermedia fell by 25% and 56%, while the untreated side showed no change. Gum redness also fell on the treated side and rose on the other (Soukos et al., 2015). In a 2024 randomized study of 31 patients with gum disease, adding a 445 nm blue laser to deep cleaning improved pocket depth more than deep cleaning alone. The laser group had started with worse gum scores, and gum attachment did not change significantly in either group (Mujić Jahić et al., 2024). A randomized crossover trial tested a 460 to 480 nm blue LED toothbrush against a manual toothbrush in 24 people wearing fixed braces. Over 28 days, the LED brush was no more effective at reducing plaque or gum inflammation, and the manual brush removed more plaque in one area beside the brackets (Manphibool et al., 2023). For more on this research, see Blue Light Therapy for Gum Disease.
Is Blue Light Safe for Gums, and Can Microbes Adapt?
In a lab study, 405 nm blue light killed more than 99.9% of the gum disease bacterium P. gingivalis within five minutes while sparing human gum cells (Yuan et al., 2023). A 2026 lab study tested two wavelengths on gum cells. Its authors concluded that 457 nm blue light had negligible harmful effects, although a marker of cell damage rose in one of the two gum cell types at most doses tested. In that same cell type, damage from 418 nm violet light rose with dose (Gait-Carr et al., 2026).
On resistance, the evidence is mostly reassuring. In lab studies, repeated low doses of blue light over 10 cycles produced no resistance in several microbes, including C. albicans (Wang et al., 2017). A C. glabrata strain exposed to blue light in the lab repeatedly for 30 days responded to the light as before. Its sensitivity to antifungal drugs and its ability to form biofilms were also unchanged (Fernandes et al., 2026). Some bacteria, however, have developed tolerance after repeated low doses in lab studies, including Staphylococcus aureus (Rapacka-Zdonczyk et al., 2019) and three other types of bacteria (Rapacka-Zdonczyk et al., 2021). A 2022 review recommends doses strong enough to kill microbes outright, because long, low-level exposures can encourage tolerance (Haridas & Atreya, 2022).
What Has Not Been Tested
In the research reviewed for this article, the trial that came closest to selecting by menopause was a 40-woman pilot. Its authors chose women of post-menopausal age because they are the patients most often seen with burning mouth syndrome (Scardina et al., 2020). No trial made menopause a formal entry requirement or reported results separately for postmenopausal women. Many trial participants are women of menopausal age, so the trial results cover the right age range. What remains untested is whether menopausal status itself changes how well light therapy works.
Several findings rest on indirect evidence. The case that light therapy repairs the damaged nerves behind burning mouth pain comes from animal and review studies; no human study has yet measured it. The taste trials studied people with cancer, COVID-19, or nerve-related mouth pain, not menopause. The bone evidence is entirely preclinical. Blue light's clinical evidence is early. A 2026 review rated its evidence for gum disease at Level 4 and found no systematic reviews of blue light alone for that use. The same review cited no clinical trial of blue light for oral thrush (Hiltch et al., 2026). These gaps make the nerve, taste, bone, and blue light findings reasons to expect benefit rather than proof of it. The clinical findings for burning mouth and dry mouth do not depend on them.
Professional guidance is still catching up. The World Association for Photobiomodulation Therapy (WALT) has issued clinical practice guidelines for burning mouth syndrome (Hanna et al., 2026). The MASCC/ISOO cancer care guidelines recommend light therapy to prevent mouth sores in specific cancer treatments, not for burning mouth syndrome (Zadik et al., 2019).
Should You Try Red and Blue Light Therapy for Oral Symptoms of Menopause?
The evidence for red light therapy is strongest for burning mouth syndrome. A clinical practice guideline, moderate-certainty evidence of pain relief, sham-controlled trials, and a large trial with 12-month follow-up all point the same way. For dry mouth, meta-analyses show more saliva and less dryness. One trial in mostly older women on medications found the gains held for a year. Gum inflammation responds in cell studies and, when light is added to deep cleaning, in clinical trials. Taste and bone evidence is promising but comes from other populations or from the lab. Blue light kills Candida and gum disease bacteria in the lab, but human results so far are mixed.
Every menopausal mouth is different, and so is every woman's mix of symptoms and medications, and what she wants from treatment. The research now shows clearly where light therapy is well supported and where it is still developing, along with the questions it has not reached yet. With that picture, you can decide or talk with your dentist and decide what fits your mouth and your life.